From: chemistry-request at ccl.net <br />
To: chemistry-request at ccl.net<br />
Date: Wed May 14 23:24:04 2008<br />
Subject: 08.06.25 <span class="fancysmall">CHI&#39;s Stucture-Based Drug Design, Boston, Massachusetts</span><br />

<pre>
CHI&#39;s Stucture-Based Drug Design
June 25-27, 2008
The World Trade Center, Boston, Massachusetts

Advanced registration discount ends May 23.

Register at <a href="http://www.healthtech.com/sbd/overview.aspx" target="_blank">http://www.healthtech.com/sbd/overview.aspx</a>

Session Topics:
* Structure-Based Modeling of GPCRs
* Determination of Protein-Protein Interaction Sites
* Computational-Based Protein Design
* Hit and Lead Optimization
* Accounting for Receptor Flexibility in Ligand Binding
* Challenges of Docking and Screening
* Experimental Approaches
* Case Studies

Distinguished Faculty:
* Matthew Clark, Ph.D., Senior Director of Scientific Computation, Locus
  Pharmaceuticals
* David Dalgarno, Ph.D., Vice President, Research Technologies, ARIAD
  Pharmaceuticals Inc.
* Stefan Geschwindner, Ph.D., Principal Scientist and Team Leader, Protein
  Engineering, Global Structural Chemistry, AstraZeneca R&amp;D
* Andrew Good, Ph.D., Principal Scientist, Computer Assisted Drug Design,
  Bristol-Myers Squibb
* Andreas Gosberg, Ph.D., Senior Scientist II, Medicinal Chemistry, SGX
  Pharmaceuticals
* Roderick E. Hubbard, Senior Fellow, Vernalis and Professor, University
  of York
* Paul Labute, Ph.D., President, Chemical Computing Group Inc.
* Jonathan S. Mason, Ph.D., Chief Scientist &amp; Divisional Director,
  Computational Chemistry &amp; Structural Biology, Lundbeck Research (Denmark)
* Stephen Mayo, Ph.D., Professor of Biology and Chemistry, California
  Institute of Technology
* Stefan Modeling, Ph.D., Head of Molecular Modeling Unit, Laboratory of
  Biological Modeling, NIH, NIDDK
* Xavier J. Morelli, Ph.D., Principal Investigator, NMR and Drug Design,
  National Center for Scientific Research (CNRS)
* Mark Mulvihill, Ph.D., Associate Director of Chemistry, Oncology, OSI
  Pharmaceuticals
* Jennifer Nemeth, Ph.D., Principal Research Scientist, Protein
  Engineering, Centocor Research and Development
* Christopher Phillips, Ph.D., Senior Principal Scientist, Exploratory
  Medicinal Sciences, Pfizer Global Research and Development
* Alan C. Rigby Ph.D., Assistant Professor of Medicine, Harvard Medical
  School
* Tomi Sawyer, Ph.D., Chief Scientific Officer, AILERON Therapeutics;
  Editor-in-Chief, Chemical Biology &amp; Drug Design
* Sharon Shacham, Ph.D., Vice President, Drug Development, EPIX
  Pharmaceuticals
* B. Woody Sherman, Ph.D., Director, Applications Science, Schrodinger, Inc.
* Lena Tagmose, Ph.D., Head of Section, Computational Chemistry, Lundbeck
  Research (Denmark)
* Gergely Toth, Ph.D., Scientist, Computational Chemistry and Biology,
  Elan Pharmaceuticals
* Thomas J. Tucker, Ph.D., Senior Research Fellow, Dept. of Medicinal
  Chemistry, Merck Research Laboratories
* T. R. Vedananda, Ph.D., Program Head, Diabetes &amp; Metabolism, Novartis
* C.M. (Venkat) Venkatachalam, Ph.D., Fellow, Accelrys, Inc.
* Zsolt Zsoldos, Co-Founder and CSO, SimBioSys

Prior to the start of this conference will be a pre-conference workshop
(Designing Kinase Inhibitors) on June 25.  Visit our website for full
details on the Structure-Based Drug Design conference and pre-conference
workshop:  <a href="http://www.healthtech.com/sbd/overview.aspx" target="_blank">http://www.healthtech.com/sbd/overview.aspx</a>

The industry has relied on CHI for many year&#39;s to deliver top-notch
science and quality networking in drug design...Don&#39;t miss out!

Be sure to register by May 23to receive the lowest conference registration
fee. To register, visit our website, or call +1 781-972-5400 or toll-free
in the U.S. 888-999-6288.

Sponsorship and Exhibit Opportunities are Available:
Exhibiting at this premier event allows you to showcase your expertise,
brand your solutions and develop revenue-generating opportunities with
qualified decision-makers.  Sponsorship packages are designed to achieve
your lead generation, business development and networking goals and
objectives. Through your sponsorship, CHI will help your company meet
these goals plus maximize exclusive sponsorship branding opportunity pre,
post and while at the Structure-Based Design conference.  Sponsorship
features include pre-conference, at-conference and post-conference
benefits providing a well-rounded marketing campaign.
For details and to contract space, contact Katelin Fitzgerald at
781-972-5458 or kfitzgerald[a]healthtech.com

Present a Poster:
Delegates are encouraged to display their recent research and progress in
structure-based design by displaying a poster.  Your poster will be
included in our conference CD that is distributed to all our delegates
on-site.  Submit a poster by June 8 and CHI will take an additional $50
off your conference registration.</pre>
<b>NOTE THAT E-MAIL ADDRESSES HAVE BEEN MODIFIED!!!</b><br />
All @ signs were changed to [a] to fight spam. Before you send e-mail, you
need to change [a] to @<br />
For example: change joe[a]big123comp.com to joe@big123comp.com<br />
<em>Please let colleagues know about conference listingts at
Computational Chemistry List Conference Page at</em>
<a href="http://www.ccl.net/chemistry/a/conferences/"
class="link">http://www.ccl.net/chemistry/a/conferences/</a>.